0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Syndromic Multiplex Test Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-21N12676
Home | Market Reports | Health| Medical Devices & Equipment
Global Syndromic Multiplex Test Market Research Report 2022
BUY CHAPTERS

Global Syndromic Multiplex Test Market Research Report 2025

Code: QYRE-Auto-21N12676
Report
March 2025
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Syndromic Multiplex Test Market

The global market for Syndromic Multiplex Test was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Syndromic Multiplex Test is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Syndromic Multiplex Test is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Syndromic Multiplex Test include Abacus Diagnostica, Abbott Diagnostics, Accelerate Diagnostics, Oxford Nanopore Technologies, Akonni Biosystems, Alveo Technologies, Antelope Dx, Applied BioCode, Aus Diagnostics, Baebies, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Syndromic Multiplex Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Syndromic Multiplex Test.
The Syndromic Multiplex Test market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Syndromic Multiplex Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Syndromic Multiplex Test manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Syndromic Multiplex Test Market Report

Report Metric Details
Report Name Syndromic Multiplex Test Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abacus Diagnostica, Abbott Diagnostics, Accelerate Diagnostics, Oxford Nanopore Technologies, Akonni Biosystems, Alveo Technologies, Antelope Dx, Applied BioCode, Aus Diagnostics, Baebies, Beckman Coulter Diagnostics, Becton, Dickinson and Company, Binx Health, Biocartis, Diasorin S.p.A, Enzo Life Sciences, Eurofins Scientific, Millipore Sigma, Fusion Genomics, Genetic Signatures, Siemens Healthineers, Maxim Biomedical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Syndromic Multiplex Test manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Syndromic Multiplex Test in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Syndromic Multiplex Test Market report?

Ans: The main players in the Syndromic Multiplex Test Market are Abacus Diagnostica, Abbott Diagnostics, Accelerate Diagnostics, Oxford Nanopore Technologies, Akonni Biosystems, Alveo Technologies, Antelope Dx, Applied BioCode, Aus Diagnostics, Baebies, Beckman Coulter Diagnostics, Becton, Dickinson and Company, Binx Health, Biocartis, Diasorin S.p.A, Enzo Life Sciences, Eurofins Scientific, Millipore Sigma, Fusion Genomics, Genetic Signatures, Siemens Healthineers, Maxim Biomedical

What are the Application segmentation covered in the Syndromic Multiplex Test Market report?

Ans: The Applications covered in the Syndromic Multiplex Test Market report are Septicemia, Tuberculosis, Others

What are the Type segmentation covered in the Syndromic Multiplex Test Market report?

Ans: The Types covered in the Syndromic Multiplex Test Market report are Blood Test Type, Urine Detection Type

Recommended Reports

Multiplex & Molecular Testing

Disease Diagnostic Solutions

IVD & Diagnostics Platforms

1 Syndromic Multiplex Test Market Overview
1.1 Product Definition
1.2 Syndromic Multiplex Test by Type
1.2.1 Global Syndromic Multiplex Test Market Value Comparison by Type (2024 VS 2031)
1.2.2 Blood Test Type
1.2.3 Urine Detection Type
1.3 Syndromic Multiplex Test by Application
1.3.1 Global Syndromic Multiplex Test Market Value by Application (2024 VS 2031)
1.3.2 Septicemia
1.3.3 Tuberculosis
1.3.4 Others
1.4 Global Syndromic Multiplex Test Market Size Estimates and Forecasts
1.4.1 Global Syndromic Multiplex Test Revenue 2020-2031
1.4.2 Global Syndromic Multiplex Test Sales 2020-2031
1.4.3 Global Syndromic Multiplex Test Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Syndromic Multiplex Test Market Competition by Manufacturers
2.1 Global Syndromic Multiplex Test Sales Market Share by Manufacturers (2020-2025)
2.2 Global Syndromic Multiplex Test Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Syndromic Multiplex Test Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Syndromic Multiplex Test, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Syndromic Multiplex Test, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Syndromic Multiplex Test, Product Type & Application
2.7 Global Key Manufacturers of Syndromic Multiplex Test, Date of Enter into This Industry
2.8 Global Syndromic Multiplex Test Market Competitive Situation and Trends
2.8.1 Global Syndromic Multiplex Test Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Syndromic Multiplex Test Players Market Share by Revenue
2.8.3 Global Syndromic Multiplex Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Syndromic Multiplex Test Market Scenario by Region
3.1 Global Syndromic Multiplex Test Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Syndromic Multiplex Test Sales by Region: 2020-2031
3.2.1 Global Syndromic Multiplex Test Sales by Region: 2020-2025
3.2.2 Global Syndromic Multiplex Test Sales by Region: 2026-2031
3.3 Global Syndromic Multiplex Test Revenue by Region: 2020-2031
3.3.1 Global Syndromic Multiplex Test Revenue by Region: 2020-2025
3.3.2 Global Syndromic Multiplex Test Revenue by Region: 2026-2031
3.4 North America Syndromic Multiplex Test Market Facts & Figures by Country
3.4.1 North America Syndromic Multiplex Test Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Syndromic Multiplex Test Sales by Country (2020-2031)
3.4.3 North America Syndromic Multiplex Test Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Syndromic Multiplex Test Market Facts & Figures by Country
3.5.1 Europe Syndromic Multiplex Test Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Syndromic Multiplex Test Sales by Country (2020-2031)
3.5.3 Europe Syndromic Multiplex Test Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Syndromic Multiplex Test Market Facts & Figures by Region
3.6.1 Asia Pacific Syndromic Multiplex Test Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Syndromic Multiplex Test Sales by Region (2020-2031)
3.6.3 Asia Pacific Syndromic Multiplex Test Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Syndromic Multiplex Test Market Facts & Figures by Country
3.7.1 Latin America Syndromic Multiplex Test Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Syndromic Multiplex Test Sales by Country (2020-2031)
3.7.3 Latin America Syndromic Multiplex Test Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Syndromic Multiplex Test Market Facts & Figures by Country
3.8.1 Middle East and Africa Syndromic Multiplex Test Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Syndromic Multiplex Test Sales by Country (2020-2031)
3.8.3 Middle East and Africa Syndromic Multiplex Test Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Syndromic Multiplex Test Sales by Type (2020-2031)
4.1.1 Global Syndromic Multiplex Test Sales by Type (2020-2025)
4.1.2 Global Syndromic Multiplex Test Sales by Type (2026-2031)
4.1.3 Global Syndromic Multiplex Test Sales Market Share by Type (2020-2031)
4.2 Global Syndromic Multiplex Test Revenue by Type (2020-2031)
4.2.1 Global Syndromic Multiplex Test Revenue by Type (2020-2025)
4.2.2 Global Syndromic Multiplex Test Revenue by Type (2026-2031)
4.2.3 Global Syndromic Multiplex Test Revenue Market Share by Type (2020-2031)
4.3 Global Syndromic Multiplex Test Price by Type (2020-2031)
5 Segment by Application
5.1 Global Syndromic Multiplex Test Sales by Application (2020-2031)
5.1.1 Global Syndromic Multiplex Test Sales by Application (2020-2025)
5.1.2 Global Syndromic Multiplex Test Sales by Application (2026-2031)
5.1.3 Global Syndromic Multiplex Test Sales Market Share by Application (2020-2031)
5.2 Global Syndromic Multiplex Test Revenue by Application (2020-2031)
5.2.1 Global Syndromic Multiplex Test Revenue by Application (2020-2025)
5.2.2 Global Syndromic Multiplex Test Revenue by Application (2026-2031)
5.2.3 Global Syndromic Multiplex Test Revenue Market Share by Application (2020-2031)
5.3 Global Syndromic Multiplex Test Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abacus Diagnostica
6.1.1 Abacus Diagnostica Company Information
6.1.2 Abacus Diagnostica Description and Business Overview
6.1.3 Abacus Diagnostica Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abacus Diagnostica Syndromic Multiplex Test Product Portfolio
6.1.5 Abacus Diagnostica Recent Developments/Updates
6.2 Abbott Diagnostics
6.2.1 Abbott Diagnostics Company Information
6.2.2 Abbott Diagnostics Description and Business Overview
6.2.3 Abbott Diagnostics Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Abbott Diagnostics Syndromic Multiplex Test Product Portfolio
6.2.5 Abbott Diagnostics Recent Developments/Updates
6.3 Accelerate Diagnostics
6.3.1 Accelerate Diagnostics Company Information
6.3.2 Accelerate Diagnostics Description and Business Overview
6.3.3 Accelerate Diagnostics Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Accelerate Diagnostics Syndromic Multiplex Test Product Portfolio
6.3.5 Accelerate Diagnostics Recent Developments/Updates
6.4 Oxford Nanopore Technologies
6.4.1 Oxford Nanopore Technologies Company Information
6.4.2 Oxford Nanopore Technologies Description and Business Overview
6.4.3 Oxford Nanopore Technologies Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Oxford Nanopore Technologies Syndromic Multiplex Test Product Portfolio
6.4.5 Oxford Nanopore Technologies Recent Developments/Updates
6.5 Akonni Biosystems
6.5.1 Akonni Biosystems Company Information
6.5.2 Akonni Biosystems Description and Business Overview
6.5.3 Akonni Biosystems Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Akonni Biosystems Syndromic Multiplex Test Product Portfolio
6.5.5 Akonni Biosystems Recent Developments/Updates
6.6 Alveo Technologies
6.6.1 Alveo Technologies Company Information
6.6.2 Alveo Technologies Description and Business Overview
6.6.3 Alveo Technologies Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Alveo Technologies Syndromic Multiplex Test Product Portfolio
6.6.5 Alveo Technologies Recent Developments/Updates
6.7 Antelope Dx
6.7.1 Antelope Dx Company Information
6.7.2 Antelope Dx Description and Business Overview
6.7.3 Antelope Dx Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Antelope Dx Syndromic Multiplex Test Product Portfolio
6.7.5 Antelope Dx Recent Developments/Updates
6.8 Applied BioCode
6.8.1 Applied BioCode Company Information
6.8.2 Applied BioCode Description and Business Overview
6.8.3 Applied BioCode Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Applied BioCode Syndromic Multiplex Test Product Portfolio
6.8.5 Applied BioCode Recent Developments/Updates
6.9 Aus Diagnostics
6.9.1 Aus Diagnostics Company Information
6.9.2 Aus Diagnostics Description and Business Overview
6.9.3 Aus Diagnostics Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Aus Diagnostics Syndromic Multiplex Test Product Portfolio
6.9.5 Aus Diagnostics Recent Developments/Updates
6.10 Baebies
6.10.1 Baebies Company Information
6.10.2 Baebies Description and Business Overview
6.10.3 Baebies Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Baebies Syndromic Multiplex Test Product Portfolio
6.10.5 Baebies Recent Developments/Updates
6.11 Beckman Coulter Diagnostics
6.11.1 Beckman Coulter Diagnostics Company Information
6.11.2 Beckman Coulter Diagnostics Description and Business Overview
6.11.3 Beckman Coulter Diagnostics Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Beckman Coulter Diagnostics Syndromic Multiplex Test Product Portfolio
6.11.5 Beckman Coulter Diagnostics Recent Developments/Updates
6.12 Becton, Dickinson and Company
6.12.1 Becton, Dickinson and Company Company Information
6.12.2 Becton, Dickinson and Company Description and Business Overview
6.12.3 Becton, Dickinson and Company Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Becton, Dickinson and Company Syndromic Multiplex Test Product Portfolio
6.12.5 Becton, Dickinson and Company Recent Developments/Updates
6.13 Binx Health
6.13.1 Binx Health Company Information
6.13.2 Binx Health Description and Business Overview
6.13.3 Binx Health Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Binx Health Syndromic Multiplex Test Product Portfolio
6.13.5 Binx Health Recent Developments/Updates
6.14 Biocartis
6.14.1 Biocartis Company Information
6.14.2 Biocartis Description and Business Overview
6.14.3 Biocartis Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Biocartis Syndromic Multiplex Test Product Portfolio
6.14.5 Biocartis Recent Developments/Updates
6.15 Diasorin S.p.A
6.15.1 Diasorin S.p.A Company Information
6.15.2 Diasorin S.p.A Description and Business Overview
6.15.3 Diasorin S.p.A Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Diasorin S.p.A Syndromic Multiplex Test Product Portfolio
6.15.5 Diasorin S.p.A Recent Developments/Updates
6.16 Enzo Life Sciences
6.16.1 Enzo Life Sciences Company Information
6.16.2 Enzo Life Sciences Description and Business Overview
6.16.3 Enzo Life Sciences Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Enzo Life Sciences Syndromic Multiplex Test Product Portfolio
6.16.5 Enzo Life Sciences Recent Developments/Updates
6.17 Eurofins Scientific
6.17.1 Eurofins Scientific Company Information
6.17.2 Eurofins Scientific Description and Business Overview
6.17.3 Eurofins Scientific Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Eurofins Scientific Syndromic Multiplex Test Product Portfolio
6.17.5 Eurofins Scientific Recent Developments/Updates
6.18 Millipore Sigma
6.18.1 Millipore Sigma Company Information
6.18.2 Millipore Sigma Description and Business Overview
6.18.3 Millipore Sigma Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Millipore Sigma Syndromic Multiplex Test Product Portfolio
6.18.5 Millipore Sigma Recent Developments/Updates
6.19 Fusion Genomics
6.19.1 Fusion Genomics Company Information
6.19.2 Fusion Genomics Description and Business Overview
6.19.3 Fusion Genomics Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Fusion Genomics Syndromic Multiplex Test Product Portfolio
6.19.5 Fusion Genomics Recent Developments/Updates
6.20 Genetic Signatures
6.20.1 Genetic Signatures Company Information
6.20.2 Genetic Signatures Description and Business Overview
6.20.3 Genetic Signatures Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Genetic Signatures Syndromic Multiplex Test Product Portfolio
6.20.5 Genetic Signatures Recent Developments/Updates
6.21 Siemens Healthineers
6.21.1 Siemens Healthineers Company Information
6.21.2 Siemens Healthineers Description and Business Overview
6.21.3 Siemens Healthineers Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Siemens Healthineers Syndromic Multiplex Test Product Portfolio
6.21.5 Siemens Healthineers Recent Developments/Updates
6.22 Maxim Biomedical
6.22.1 Maxim Biomedical Company Information
6.22.2 Maxim Biomedical Description and Business Overview
6.22.3 Maxim Biomedical Syndromic Multiplex Test Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Maxim Biomedical Syndromic Multiplex Test Product Portfolio
6.22.5 Maxim Biomedical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Syndromic Multiplex Test Industry Chain Analysis
7.2 Syndromic Multiplex Test Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Syndromic Multiplex Test Production Mode & Process Analysis
7.4 Syndromic Multiplex Test Sales and Marketing
7.4.1 Syndromic Multiplex Test Sales Channels
7.4.2 Syndromic Multiplex Test Distributors
7.5 Syndromic Multiplex Test Customer Analysis
8 Syndromic Multiplex Test Market Dynamics
8.1 Syndromic Multiplex Test Industry Trends
8.2 Syndromic Multiplex Test Market Drivers
8.3 Syndromic Multiplex Test Market Challenges
8.4 Syndromic Multiplex Test Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Syndromic Multiplex Test Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Syndromic Multiplex Test Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Syndromic Multiplex Test Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Syndromic Multiplex Test Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Syndromic Multiplex Test Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Syndromic Multiplex Test Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Syndromic Multiplex Test Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Syndromic Multiplex Test Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Syndromic Multiplex Test, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Syndromic Multiplex Test, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Syndromic Multiplex Test, Product Type & Application
 Table 12. Global Key Manufacturers of Syndromic Multiplex Test, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Syndromic Multiplex Test by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Syndromic Multiplex Test as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Syndromic Multiplex Test Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Syndromic Multiplex Test Sales by Region (2020-2025) & (K Units)
 Table 18. Global Syndromic Multiplex Test Sales Market Share by Region (2020-2025)
 Table 19. Global Syndromic Multiplex Test Sales by Region (2026-2031) & (K Units)
 Table 20. Global Syndromic Multiplex Test Sales Market Share by Region (2026-2031)
 Table 21. Global Syndromic Multiplex Test Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Syndromic Multiplex Test Revenue Market Share by Region (2020-2025)
 Table 23. Global Syndromic Multiplex Test Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Syndromic Multiplex Test Revenue Market Share by Region (2026-2031)
 Table 25. North America Syndromic Multiplex Test Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Syndromic Multiplex Test Sales by Country (2020-2025) & (K Units)
 Table 27. North America Syndromic Multiplex Test Sales by Country (2026-2031) & (K Units)
 Table 28. North America Syndromic Multiplex Test Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Syndromic Multiplex Test Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Syndromic Multiplex Test Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Syndromic Multiplex Test Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Syndromic Multiplex Test Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Syndromic Multiplex Test Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Syndromic Multiplex Test Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Syndromic Multiplex Test Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Syndromic Multiplex Test Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Syndromic Multiplex Test Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Syndromic Multiplex Test Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Syndromic Multiplex Test Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Syndromic Multiplex Test Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Syndromic Multiplex Test Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Syndromic Multiplex Test Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Syndromic Multiplex Test Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Syndromic Multiplex Test Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Syndromic Multiplex Test Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Syndromic Multiplex Test Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Syndromic Multiplex Test Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Syndromic Multiplex Test Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Syndromic Multiplex Test Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Syndromic Multiplex Test Sales (K Units) by Type (2020-2025)
 Table 51. Global Syndromic Multiplex Test Sales (K Units) by Type (2026-2031)
 Table 52. Global Syndromic Multiplex Test Sales Market Share by Type (2020-2025)
 Table 53. Global Syndromic Multiplex Test Sales Market Share by Type (2026-2031)
 Table 54. Global Syndromic Multiplex Test Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Syndromic Multiplex Test Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Syndromic Multiplex Test Revenue Market Share by Type (2020-2025)
 Table 57. Global Syndromic Multiplex Test Revenue Market Share by Type (2026-2031)
 Table 58. Global Syndromic Multiplex Test Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Syndromic Multiplex Test Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Syndromic Multiplex Test Sales (K Units) by Application (2020-2025)
 Table 61. Global Syndromic Multiplex Test Sales (K Units) by Application (2026-2031)
 Table 62. Global Syndromic Multiplex Test Sales Market Share by Application (2020-2025)
 Table 63. Global Syndromic Multiplex Test Sales Market Share by Application (2026-2031)
 Table 64. Global Syndromic Multiplex Test Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Syndromic Multiplex Test Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Syndromic Multiplex Test Revenue Market Share by Application (2020-2025)
 Table 67. Global Syndromic Multiplex Test Revenue Market Share by Application (2026-2031)
 Table 68. Global Syndromic Multiplex Test Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Syndromic Multiplex Test Price (US$/Unit) by Application (2026-2031)
 Table 70. Abacus Diagnostica Company Information
 Table 71. Abacus Diagnostica Description and Business Overview
 Table 72. Abacus Diagnostica Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Abacus Diagnostica Syndromic Multiplex Test Product
 Table 74. Abacus Diagnostica Recent Developments/Updates
 Table 75. Abbott Diagnostics Company Information
 Table 76. Abbott Diagnostics Description and Business Overview
 Table 77. Abbott Diagnostics Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Abbott Diagnostics Syndromic Multiplex Test Product
 Table 79. Abbott Diagnostics Recent Developments/Updates
 Table 80. Accelerate Diagnostics Company Information
 Table 81. Accelerate Diagnostics Description and Business Overview
 Table 82. Accelerate Diagnostics Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Accelerate Diagnostics Syndromic Multiplex Test Product
 Table 84. Accelerate Diagnostics Recent Developments/Updates
 Table 85. Oxford Nanopore Technologies Company Information
 Table 86. Oxford Nanopore Technologies Description and Business Overview
 Table 87. Oxford Nanopore Technologies Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Oxford Nanopore Technologies Syndromic Multiplex Test Product
 Table 89. Oxford Nanopore Technologies Recent Developments/Updates
 Table 90. Akonni Biosystems Company Information
 Table 91. Akonni Biosystems Description and Business Overview
 Table 92. Akonni Biosystems Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Akonni Biosystems Syndromic Multiplex Test Product
 Table 94. Akonni Biosystems Recent Developments/Updates
 Table 95. Alveo Technologies Company Information
 Table 96. Alveo Technologies Description and Business Overview
 Table 97. Alveo Technologies Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Alveo Technologies Syndromic Multiplex Test Product
 Table 99. Alveo Technologies Recent Developments/Updates
 Table 100. Antelope Dx Company Information
 Table 101. Antelope Dx Description and Business Overview
 Table 102. Antelope Dx Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Antelope Dx Syndromic Multiplex Test Product
 Table 104. Antelope Dx Recent Developments/Updates
 Table 105. Applied BioCode Company Information
 Table 106. Applied BioCode Description and Business Overview
 Table 107. Applied BioCode Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Applied BioCode Syndromic Multiplex Test Product
 Table 109. Applied BioCode Recent Developments/Updates
 Table 110. Aus Diagnostics Company Information
 Table 111. Aus Diagnostics Description and Business Overview
 Table 112. Aus Diagnostics Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Aus Diagnostics Syndromic Multiplex Test Product
 Table 114. Aus Diagnostics Recent Developments/Updates
 Table 115. Baebies Company Information
 Table 116. Baebies Description and Business Overview
 Table 117. Baebies Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Baebies Syndromic Multiplex Test Product
 Table 119. Baebies Recent Developments/Updates
 Table 120. Beckman Coulter Diagnostics Company Information
 Table 121. Beckman Coulter Diagnostics Description and Business Overview
 Table 122. Beckman Coulter Diagnostics Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Beckman Coulter Diagnostics Syndromic Multiplex Test Product
 Table 124. Beckman Coulter Diagnostics Recent Developments/Updates
 Table 125. Becton, Dickinson and Company Company Information
 Table 126. Becton, Dickinson and Company Description and Business Overview
 Table 127. Becton, Dickinson and Company Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Becton, Dickinson and Company Syndromic Multiplex Test Product
 Table 129. Becton, Dickinson and Company Recent Developments/Updates
 Table 130. Binx Health Company Information
 Table 131. Binx Health Description and Business Overview
 Table 132. Binx Health Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Binx Health Syndromic Multiplex Test Product
 Table 134. Binx Health Recent Developments/Updates
 Table 135. Biocartis Company Information
 Table 136. Biocartis Description and Business Overview
 Table 137. Biocartis Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Biocartis Syndromic Multiplex Test Product
 Table 139. Biocartis Recent Developments/Updates
 Table 140. Diasorin S.p.A Company Information
 Table 141. Diasorin S.p.A Description and Business Overview
 Table 142. Diasorin S.p.A Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Diasorin S.p.A Syndromic Multiplex Test Product
 Table 144. Diasorin S.p.A Recent Developments/Updates
 Table 145. Enzo Life Sciences Company Information
 Table 146. Enzo Life Sciences Description and Business Overview
 Table 147. Enzo Life Sciences Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Enzo Life Sciences Syndromic Multiplex Test Product
 Table 149. Enzo Life Sciences Recent Developments/Updates
 Table 150. Eurofins Scientific Company Information
 Table 151. Eurofins Scientific Description and Business Overview
 Table 152. Eurofins Scientific Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Eurofins Scientific Syndromic Multiplex Test Product
 Table 154. Eurofins Scientific Recent Developments/Updates
 Table 155. Millipore Sigma Company Information
 Table 156. Millipore Sigma Description and Business Overview
 Table 157. Millipore Sigma Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Millipore Sigma Syndromic Multiplex Test Product
 Table 159. Millipore Sigma Recent Developments/Updates
 Table 160. Fusion Genomics Company Information
 Table 161. Fusion Genomics Description and Business Overview
 Table 162. Fusion Genomics Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Fusion Genomics Syndromic Multiplex Test Product
 Table 164. Fusion Genomics Recent Developments/Updates
 Table 165. Genetic Signatures Company Information
 Table 166. Genetic Signatures Description and Business Overview
 Table 167. Genetic Signatures Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Genetic Signatures Syndromic Multiplex Test Product
 Table 169. Genetic Signatures Recent Developments/Updates
 Table 170. Siemens Healthineers Company Information
 Table 171. Siemens Healthineers Description and Business Overview
 Table 172. Siemens Healthineers Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Siemens Healthineers Syndromic Multiplex Test Product
 Table 174. Siemens Healthineers Recent Developments/Updates
 Table 175. Maxim Biomedical Company Information
 Table 176. Maxim Biomedical Description and Business Overview
 Table 177. Maxim Biomedical Syndromic Multiplex Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Maxim Biomedical Syndromic Multiplex Test Product
 Table 179. Maxim Biomedical Recent Developments/Updates
 Table 180. Key Raw Materials Lists
 Table 181. Raw Materials Key Suppliers Lists
 Table 182. Syndromic Multiplex Test Distributors List
 Table 183. Syndromic Multiplex Test Customers List
 Table 184. Syndromic Multiplex Test Market Trends
 Table 185. Syndromic Multiplex Test Market Drivers
 Table 186. Syndromic Multiplex Test Market Challenges
 Table 187. Syndromic Multiplex Test Market Restraints
 Table 188. Research Programs/Design for This Report
 Table 189. Key Data Information from Secondary Sources
 Table 190. Key Data Information from Primary Sources
 Table 191. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Syndromic Multiplex Test
 Figure 2. Global Syndromic Multiplex Test Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Syndromic Multiplex Test Market Share by Type: 2024 & 2031
 Figure 4. Blood Test Type Product Picture
 Figure 5. Urine Detection Type Product Picture
 Figure 6. Global Syndromic Multiplex Test Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Syndromic Multiplex Test Market Share by Application: 2024 & 2031
 Figure 8. Septicemia
 Figure 9. Tuberculosis
 Figure 10. Others
 Figure 11. Global Syndromic Multiplex Test Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Syndromic Multiplex Test Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Syndromic Multiplex Test Sales (2020-2031) & (K Units)
 Figure 14. Global Syndromic Multiplex Test Average Price (US$/Unit) & (2020-2031)
 Figure 15. Syndromic Multiplex Test Report Years Considered
 Figure 16. Syndromic Multiplex Test Sales Share by Manufacturers in 2024
 Figure 17. Global Syndromic Multiplex Test Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Syndromic Multiplex Test Players: Market Share by Revenue in Syndromic Multiplex Test in 2024
 Figure 19. Syndromic Multiplex Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Syndromic Multiplex Test Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Syndromic Multiplex Test Sales Market Share by Country (2020-2031)
 Figure 22. North America Syndromic Multiplex Test Revenue Market Share by Country (2020-2031)
 Figure 23. United States Syndromic Multiplex Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Syndromic Multiplex Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Syndromic Multiplex Test Sales Market Share by Country (2020-2031)
 Figure 26. Europe Syndromic Multiplex Test Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Syndromic Multiplex Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Syndromic Multiplex Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Syndromic Multiplex Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Syndromic Multiplex Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Syndromic Multiplex Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Syndromic Multiplex Test Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Syndromic Multiplex Test Revenue Market Share by Region (2020-2031)
 Figure 34. China Syndromic Multiplex Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Syndromic Multiplex Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Syndromic Multiplex Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Syndromic Multiplex Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Syndromic Multiplex Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Syndromic Multiplex Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Syndromic Multiplex Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Syndromic Multiplex Test Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Syndromic Multiplex Test Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Syndromic Multiplex Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Syndromic Multiplex Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Syndromic Multiplex Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Syndromic Multiplex Test Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Syndromic Multiplex Test Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Syndromic Multiplex Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Syndromic Multiplex Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Syndromic Multiplex Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Syndromic Multiplex Test by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Syndromic Multiplex Test by Type (2020-2031)
 Figure 53. Global Syndromic Multiplex Test Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Syndromic Multiplex Test by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Syndromic Multiplex Test by Application (2020-2031)
 Figure 56. Global Syndromic Multiplex Test Price (US$/Unit) by Application (2020-2031)
 Figure 57. Syndromic Multiplex Test Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart